Technology Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42% Last updated: October 23, 2026 2:12 am By The True Post No Comments Share SHARE Markers released top-line results today after previously reporting the trial succeeded. Source: Ars Technica TAGGED:cancerHealthmelanomamerckmoderna Share This Article Copy Link Print ByThe True PostThe newsroom of The True Post. Leave a Comment Leave a Comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.